News Releases
May 24, 2022
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria
April 28, 2022
Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium
April 26, 2022
Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
April 1, 2022
Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting
March 17, 2022
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
January 6, 2022
Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences
Displaying 49 - 60 of 222